•
SA
SANA
Sana Biotechnology, Inc. Common Stock
yahooBIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
--
Price Chart
Market Cap
1.27B
Volume
2.23M
52W High
$6.55
52W Low
$1.26
Open
$0.00
Prev Close
$4.58
Day Range
0.00 - 0.00
About Sana Biotechnology, Inc. Common Stock
Sana Biotechnology Inc is a biotechnology company. The company develops engineered cells as medicines and therapies to treat diseases. It is engaged in developing cell engineering programs for across a broad array of therapeutic areas with unmet treatment needs, including oncology, diabetes, B-cell-mediated autoimmune, and central nervous system (CNS) disorders, among others. Its pipeline of product candidates is comprised of SC291, SC262, SC255, UP421 and others.
Latest News
Sana Biotechnology Announces Publication in Nature Biotechnology of in vivo Gene Editing of Human Hematopoietic Stem Cells in Preclinical Models Using the Fusogen Platform
GlobeNewswire Inc.•Dec 8
Sana Biotech Stock — The Next '100-Bagger'?
Benzinga•Oct 15
Quell Therapeutics Establishes World-Class Scientific Advisory Board
GlobeNewswire Inc.•Aug 27
Sana Biotechnology Announces Pricing of Public Offering
Benzinga•Aug 7
Sana Biotechnology Announces Pricing of Public Offering
GlobeNewswire Inc.•Aug 7
Draig Therapeutics Appoints Experienced Biotech Leader Douglas E. Williams, Ph.D. as Chair of its Board of Directors
GlobeNewswire Inc.•Jul 15
SANA Investors Have Opportunity to Lead Sana Biotechnology, Inc. Securities Fraud Lawsuit with the Schall Law Firm
Benzinga•May 19
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Sana Biotechnology
GlobeNewswire Inc.•May 14